Ergün Eser L, Kiratli Pinar O, Günay Emel C, Erbaş Belkis
Department of Nuclear Medicine, School of Medicine, Hacettepe University, Ankara, Turkey.
Nucl Med Commun. 2006 Nov;27(11):877-85. doi: 10.1097/01.mnm.0000237991.44948.13.
In addition to well-known specific conditions for soft-tissue uptake of bone-seeking radiotracers, there is a limited number of reports on intestinal uptake of (99m)Tc-methylene diphosphonate ((99m)Tc-MDP) on bone scans.
To describe the incidence of intestinal accumulation of (99m)Tc-MDP on bone scans in adult patients, define the patterns of this unusual finding and review the literature on its causes.
Two thousand, one hundred and forty-four consecutive patients have been evaluated for intestinal (99m)Tc-MDP uptake on bone scans. Intestinal uptake was observed visually 3-4 h after the administration of the radiopharmaceutical. A whole-body bone scan and various spot views of the abdomino-pelvic region were obtained with a dual-headed gamma camera to evaluate the intestinal uptake. Delayed scans were also obtained as well as co-relative imaging and/or colonoscopic studies in some of intestinal uptake patients. Six patients had delayed scans of the abdomino-pelvic region. Fourteen patients had comparable scans either a year before or a year later. The positive intestinal uptake scans were further grouped according to the localization and intensity (mild uptake: lower than iliac bone; moderate uptake: equal to iliac bone; significant uptake: higher than iliac bone).
Twenty-two (17 female, five male) patients out of 2144 with a mean age of 57 years showed intestinal (99m)Tc-MDP uptake. The localization was mainly (20/22) in the right abdomino-pelvic region projecting on and in the configuration of ascending colon while one patient showed intestinal uptake all over the abdomen and one displayed diffuse intestinal radioactivity in his right hemithorax. The majority of the cases showed moderate to intense intestinal uptake (18/22). Six patients showed a decrease, disappearance or alteration in the intestinal uptake on the delayed images. Re-evaluation bone scans in five patients 1 year later showed no intestinal uptake this time. Among nine patients with prior bone scans 1 year before, intestinal uptake was negative in seven at that time. No significant pathology was obtained on the correlative images.
(99m)Tc-MDP uptake can be observed in the intestines in 1% of bone scans with a prominent localization in the ascending colon and rarely all over the intestines or in thorax due to Chilaiditi's syndrome, as well. The mechanism of intestinal uptake is still unclear in some of the patients. Delayed imaging, additional spot views and SPECT studies help in the differentiation of this finding from possible misinterpretation. Intestinal (99m)Tc-MDP uptake on bone scan could be an intermittent process and should be included among other well-known reasons of soft-tissue uptake.
除了众所周知的亲骨性放射性示踪剂软组织摄取的特定情况外,关于骨扫描中(99m)锝-亚甲基二膦酸盐((99m)Tc-MDP)肠道摄取的报道数量有限。
描述成年患者骨扫描中(99m)Tc-MDP肠道积聚的发生率,确定这一异常发现的模式,并复习其病因的相关文献。
对2144例连续患者进行骨扫描时评估肠道(99m)Tc-MDP摄取情况。在给予放射性药物后3 - 4小时通过肉眼观察肠道摄取情况。使用双头γ相机进行全身骨扫描及腹部盆腔区域的各种局部图像,以评估肠道摄取情况。还进行了延迟扫描,并且对一些肠道摄取患者进行了相关成像和/或结肠镜检查。6例患者进行了腹部盆腔区域的延迟扫描。14例患者在一年前或一年后进行了对照扫描。阳性肠道摄取扫描根据定位和强度进一步分组(轻度摄取:低于髂骨;中度摄取:等于髂骨;显著摄取:高于髂骨)。
2144例患者中有22例(17例女性,5例男性)平均年龄57岁,显示肠道有(99m)Tc-MDP摄取。定位主要(20/22)在右腹部盆腔区域,投影于升结肠并呈其形态,1例患者全腹部显示肠道摄取,1例患者右半胸显示弥漫性肠道放射性。大多数病例显示中度至强烈的肠道摄取(18/22)。6例患者在延迟图像上显示肠道摄取减少、消失或改变。5例患者1年后复查骨扫描时此次未显示肠道摄取。9例一年前有过骨扫描的患者中,当时7例肠道摄取为阴性。相关图像未发现明显病变。
在1%的骨扫描中可观察到肠道有(99m)Tc-MDP摄取,主要定位于升结肠,极少因奇莱迪蒂综合征而全肠道或在胸部出现。部分患者肠道摄取的机制仍不清楚。延迟成像、额外的局部图像和单光子发射计算机断层扫描(SPECT)研究有助于将这一发现与可能的误解区分开来。骨扫描中肠道(99m)Tc-MDP摄取可能是一个间歇性过程,应列入软组织摄取的其他已知原因之中。